Sermorelin 'results' on TikTok: what the science actually supports

What did @rlt_km actually say?

In three nights of sermorelin use, @rlt_km reported two main experiences: disrupted, shallow sleep on nights one and two, and waking up nauseous and foggy the morning after that first dose. By morning three, they felt noticeably better, with more energy and a good workout. They attributed the nausea to sermorelin after looking it up online.

To be fair, this is a pretty honest account. No wild claims about fat loss or muscle gain. No dosing advice. Just someone logging what their body did, which is more responsible than most peptide content on this app. The transcript is careful to say "we'll see" rather than overselling results. That said, a few things are worth examining more closely.

Does the science back this up?

Yes, mostly. The sleep disruption in early sermorelin use is the most scientifically interesting part of this video, and it checks out. Sermorelin is a growth hormone-releasing hormone (GHRH) analogue. It works by stimulating the pituitary to release endogenous GH in pulses. GH secretion is tightly linked to slow-wave sleep (SWS), and when you artificially amplify those pulses early on, sleep architecture can get disrupted before it normalizes.

Van Cauter et al. (2000, Journal of Sleep Research) documented the relationship between GH pulsatility and SWS, showing that GH release is not just sleep-dependent but sleep-architecture-dependent. When that system gets a new input, the first few nights are often the messiest. The nausea is also plausible. GH secretagogues can transiently elevate IGF-1 and cause fluid retention and GI sensitivity, especially early on. Sigalos and Pastuszak (2018, Sexual Medicine Reviews) noted nausea and headache as early adverse effects in GH peptide studies.

What did they get wrong (or right)?

They got the general arc right. Disrupted sleep early, improvement by day three. That matches what's seen in clinical use. But there's a gap in their reasoning: attributing the nausea specifically to sermorelin based on a quick internet search is a little fast. Nausea on day two after a new compound could be sermorelin, could be coincidental illness, could be dehydration, could be something in the formulation. "I looked it up and it's one of the symptoms" is not the same as establishing causation.

Also worth flagging: @rlt_km says they "usually have a hard time sleeping," which means their baseline is already disrupted. Using sleep quality as an early efficacy signal in someone with pre-existing sleep issues is tricky. You need more than three nights of subjective sleep impression to draw any conclusions, especially if you're already a poor sleeper. The good news is they seem to know this. "Time will tell" is the right call.

What should you actually know?

Sermorelin is a prescription-only peptide in the US. It's not a supplement. It stimulates GH release indirectly, which means it operates through your own pituitary, unlike synthetic GH injections. That distinction matters for safety and for realistic expectations.

The early side effect window, typically days one through five, is when most transient effects show up: sleep changes, water retention, mild nausea, injection site reactions. These generally resolve. But "it got better by day three" is not the same as "this compound is safe and effective for me long-term." Anyone using sermorelin should be doing so under medical supervision with baseline and follow-up IGF-1 monitoring. The research on sermorelin is also thinner than for some other GHRH analogues. Prakash and Mehtani (2018, Indian Journal of Endocrinology and Metabolism) note that while GHRH analogues show promise, long-term outcome data in otherwise healthy adults remains limited. Three days is a very short window.

Bottom line: is this worth watching?

As peptide content goes, this one is relatively low-harm. @rlt_km isn't selling anything, isn't prescribing doses, and isn't claiming sermorelin cured their sleep disorder. They're documenting early personal experience with appropriate uncertainty. That's the baseline we'd want from anyone sharing this kind of content.

What it lacks is clinical context. Viewers who don't already understand how GHRH analogues work might interpret "I feel good, energized" on day three as proof the peptide is working, when it's far too early to say that. Sermorelin's effects on body composition and sleep architecture take weeks to months to assess meaningfully. Three nights of anecdote, even honest anecdote, is not data.